Pharmacotherapy of cerebral ischemia

Author： Ducruet Andrew F   Grobelny Bartosz T   Zacharia Brad E   Hickman Zachary L   Yeh Mason L   Connolly E Sander  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.12, 2009-08, pp. : 1895-1906

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective Properties of Erythropoietin in Cerebral Ischemia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-01 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Magnesium as a Neuroprotective Agent in Cerebral Ischemia

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 4, 2004-12 ,pp. : 215-222

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 21, 2015-01 ,pp. : 2211-2221

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia

By  

Current Pharmaceutical Design, Vol. 14, Iss. 23, 2008-01 ,pp. : 2347-2361

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of cerebral ischemia on dopamine receptors in the gerbil striatum

By Araki T.   Kato H.   Shuto K.   Fujiwara T.   Kogure K.   Itoyama Y.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite